Motorist Disorientation Syndrome: A Retrospective Longitudinal Case Series of Driving- Related Spatial Disorientation
Abstract
Abstract Background Motorist disorientation syndrome (MDS) is a rare and under-recognised condition characterised by dizziness, spatial disorientation, and disturbed perception of vehicle motion during driving. Its clinical boundaries, comorbidities, ancillary findings, and management remain insufficiently defined. Methods We performed a retrospective longitudinal case series of five patients evaluated for MDS at a tertiary neuro-otological and neurological centre between June 2024 and June 2026. Clinical records were reviewed for symptom profile, provoking situations, comorbidities, examination findings, ancillary tests, treatment, and 3-month outcomes. Results The cohort comprised three men and two women, with a mean age of 39.4 ± 10.4 years. Two patients had primary MDS, whereas three had secondary or associated MDS following benign paroxysmal positional vertigo, persistent postural-perceptual dizziness (PPPD), and PPPD secondary to vestibular neuritis. Symptoms were provoked by specific driving situations, including higher speeds, bends, multilane roads, bridges, overtaking, tunnels, and nearby moving vehicles. Comorbidities included migraine, motion sickness, anxiety-related symptoms, panic attacks, tetany, acrophobia, and ophthalmological disorders. Vestibular and ocular motor testing was largely normal or non-specific. Management was individualised and multimodal. All patients showed a reduction in symptom burden at 3-month follow-up, although residual symptoms…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.